Drug Type Mesenchymal stem cell therapy |
Synonyms Bone-marrow derived MSCs(The University of Queensland), bone marrow-derived mesenchymal stromal cells(The University of Queensland) |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Allograft Rejection | Phase 2 | AU | 21 Apr 2017 | |
Lung transplant rejection | Preclinical | AU | 31 Mar 2020 | |
Liver Cirrhosis, Alcoholic | Preclinical | US | 20 Jun 2019 | |
Cardiomyopathy, Dilated | Preclinical | ES | 31 Mar 2013 | |
Coronary Artery Disease | Preclinical | ES | 31 Mar 2013 | |
Idiopathic cardiomyopathy | Preclinical | ES | 31 Mar 2013 |
Phase 3 | 475 | (Bone Marrow Derived MSCs) | fomwoulmqy(yvlniruchf) = ordleysyhc itihqfbsrn (fefvywmust, gnyzuzgonb - nlxlltvnah) View more | - | 27 Jul 2023 | ||
Adipose-derived MSCs (Adipose-derived MSCs) | fomwoulmqy(yvlniruchf) = spzxegpdog itihqfbsrn (fefvywmust, fwrheqodgn - fhkfcowpjc) View more |